l 636499 has been researched along with thromboxanes in 1 studies
Studies (l 636499) | Trials (l 636499) | Recent Studies (post-2010) (l 636499) | Studies (thromboxanes) | Trials (thromboxanes) | Recent Studies (post-2010) (thromboxanes) |
---|---|---|---|---|---|
9 | 0 | 0 | 3,202 | 149 | 199 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Hatmi, M; Joseph, D; Vargaftig, B | 1 |
1 other study(ies) available for l 636499 and thromboxanes
Article | Year |
---|---|
Interference of the thromboxane antagonist SK&F 88046 with platelet activation and subsequent desensitization by arachidonic acid and the thromboxane mimetics U46619 and EP171.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Arachidonic Acid; Arachidonic Acids; Blood Platelets; Dibenzothiepins; Drug Interactions; Humans; Platelet Aggregation; Prostaglandin Endoperoxides, Synthetic; Receptors, Cell Surface; Sulfonamides; Thromboxane A2; Thromboxanes | 1987 |